NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/11/2024
Back to search
Official data from USPTO
CATSCI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CATSCI
ST13
US500000097920124Class
40, 42, 44
Filing
97920124
Registration
7412002
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
06/11/2024
Classification
Registered
Trademark type
Word
Nice classes
40, 42, 44
Filing date
05/04/2023
Registration date
06/11/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2024
Last transaction
06/11/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Wentloog, Cardiff, GB
Examiner
THOMAS,AMY E
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
CatSci Group Holdings Limited
Representatives
Bradley M. Stohry Reichel Stohry Dean LLP
Technical classification
Nice Classes
Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of pharmaceuticals; Custom manufacture of biopharmaceuticals
Class 42
Consulting services for others in the field of designplanningimplementation project management of research and development for medical and pharmaceutical innovation projects; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the field of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical products; Scientific research in the nature of conducting clinical trials for others in the field of medical products
Class 44
Pharmaceutical advice; Providing health information in the field of pharmaceuticals; Providing health information in the field of medical products; Providing medical advice in the field of medical products
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2024
PUBO
PUBLISHED FOR OPPOSITION
03/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/15/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/14/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/14/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/30/2024
GNRT
NON-FINAL ACTION E-MAILED
01/30/2024
CNRT
NON-FINAL ACTION WRITTEN
01/30/2024
DOCK
ASSIGNED TO EXAMINER
01/30/2024
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/02/2023
ALIE
ASSIGNED TO LIE
10/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/02/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/10/2023
NWAP
NEW APPLICATION ENTERED
05/08/2023
Continuous trademark protection
Get notified about every new filing that threatens CATSCI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.